ReoPro Observational Registry (RAPOR): insights from the multicentre use of abciximab in Asia.

Article

ReoPro Observational Registry (RAPOR): insights from the multicentre use of abciximab in Asia.

Kian Keong Poh,Huay Cheem Tan,James Yip,Yean Teng Lim-2005-08-01-PubMed

1

TL;DRAbstract

Abxicimab was uncommonly used among patients (9.4 percent) undergoing PCI in this Asian region, with the operators reserving it mainly for high-risk patients.

Chat with Paper

AI Agents for this Paper

Abxicimab was uncommonly used among patients (9.4 percent) undergoing PCI in this Asian region, with the operators reserving it mainly for high-risk patients.

Keywords

AbciximabMedicineConventional PCIPercutaneous coronary interventionMyocardial infarctionCohortInternal medicineComplication

Chat

Click to start Chat